Living in Málaga? New cancer therapy trials could offer eligible patients another treatment option

Cancer patients living on the Costa del Sol could potentially access an advanced treatment using their own immune cells, with clinical trials now underway through Málaga’s public health system.

Hospital Regional Universitario de Málaga has consolidated several clinical trials using TIL therapy for patients with advanced melanoma and non-small cell lung cancer.

The significance for people living on the Costa del Sol is simple. This research is taking place within Andalucía’s public health system, here in Málaga.

It does not mean the treatment is available to every patient with melanoma or lung cancer. Access is through the relevant clinical trial, and specialists assess each patient individually to determine whether they are suitable.

Could a foreign resident access the trial?

For international residents already receiving their healthcare through the Andalusian public health system, being British, Irish or another nationality is not what determines suitability for the treatment.

The important questions are whether the patient is being treated within the system and whether their particular cancer and medical circumstances meet the criteria for one of the trials.

Hospital treatment in Andalucía is normally accessed following referral by healthcare professionals, rather than by patients simply booking a hospital specialist themselves.

So, if you are being treated for advanced melanoma or non-small cell lung cancer, this is something you can discuss with the medical team responsible for your care.

The Andalusian Health Service says the Málaga trials are expanding treatment possibilities for patients with advanced disease.

What exactly is TIL therapy?

The science sounds complicated, but the basic idea is relatively straightforward.

TIL stands for tumour-infiltrating lymphocytes. These are immune cells that have already managed to enter a patient’s tumour.

Doctors obtain tumour tissue and identify these immune cells. The cells are then sent to a specialist laboratory, where they are multiplied in large numbers before being returned to the patient.

The aim is to give the body’s own immune response greater strength to attack the cancer.

Patients receive preparatory treatment before the cells are administered, and depending on the clinical trial, additional medicines may also be used.

It is a highly specialised process involving several hospital departments and medical teams.

Why this matters particularly on the Costa del Sol

Melanoma is already a significant concern in Málaga province.

As EWN previously reported on Málaga’s rising melanoma cases, around 500 new cases are diagnosed in the province each year.

Hospital Regional Universitario de Málaga itself recorded more than 180 melanoma cases in 2024, twice the annual number seen a decade earlier.

For a region with a large international population and a lifestyle that often revolves around spending time outdoors, developments in melanoma treatment are particularly relevant.

The new trials are focused on advanced disease, however. They are not a replacement for melanoma prevention, early diagnosis or existing cancer treatments.

Who decides whether you can receive TIL therapy?

There is no simple sign-up process.

Specialists assess potential participants individually. According to the hospital, considerations include the type and progression of the tumour, treatments already received, whether suitable tumour tissue can be obtained and the patient’s overall health.

That distinction is important. Someone cannot simply request TIL therapy because they have been diagnosed with melanoma or lung cancer.

But for an eligible patient already undergoing cancer treatment in Andalucía, having these trials available in Málaga could open another possibility that previously may not have existed locally.

Málaga becoming a centre for advanced cancer research

The TIL programme has been developing since 2024 and involves the hospital’s Medical Oncology Service together with researchers from IBIMA Plataforma Bionand.

It forms part of broader cancer research taking place in Málaga, with clinical trials investigating new medicines, immunotherapies and cellular therapies.

EWN has previously reported on other clinical research taking place at Málaga hospitals, although that study was separate from the current TIL cancer programme.

For foreign residents, the most important message from the latest development is not that a new cancer cure has suddenly arrived in Málaga.

It is that highly specialised cancer research is being carried out within the same Andalusian public health system used by thousands of international residents on the Costa del Sol.

For someone being treated for advanced melanoma or non-small cell lung cancer, that makes the possibility worth discussing with their medical team.